Monterrey, Mexico, March, 07, 2025 – Auna S.A. (NYSE: AUNA)
(“Auna” or the “Company”), a Latin American healthcare
company with operations in Mexico, Peru, and Colombia, announced today the
signing of an exclusive five-year agreement with a physician group practicing
at Organización Para Cuidado Integral en Oncología, S.A. de C.V.
known as Opción Oncología, the premier oncology ambulatory
clinic in Monterrey. This strategic partnership strengthens Auna’s
commitment to becoming the leading oncology provider in Mexico and marks a
significant step in consolidating oncology services within Auna Mexico.
As part of this agreement, eight highly regarded physicians – six
oncologists and two radiation oncologists – will join Auna. Today, their
practice manages approximately 30% of all private oncology treatments in
Monterrey, referring patients to multiple facilities across the city. Through
this partnership, Auna will integrate 100% of these treatments within its
network over time, strengthening care coordination and enhancing the patient
experience.
The team will relocate to Doctors Hospital, further strengthening Auna’s
oncology capabilities. This move will position Auna’s Oncology Center as
one of the few multidisciplinary and fully integrated oncology centers
operating in Mexico’s private healthcare market. Among the distinguished
doctors joining Auna are Dr. César González de León and
Dr. Cuauhtémoc De la Peña Hinojosa, both recognized as leading
oncologists in Mexico and widely referenced in their field. Dr.
González will play a key leadership role on Auna’s Oncology
Board, serving as Chair of Medical Oncology and Co-Chair of the practice for
Auna’s Center of Excellence in Oncology in Mexico. Dr. De la Peña
Hinojosa will lead Radiation Oncology as Chair of Radiation Oncology on Auna
Mexico’s Oncology Board.
This partnership strengthens Auna’s ongoing expansion and Auna’s
commitment to delivering world-class oncology care. It follows the successful
launch of OncoMexico last year and aligns with the upcoming inauguration of
Auna’s Oncology Research Center in Mexico. This new research facility
will collaborate with Auna’s existing research centers in Peru and
Colombia, driving clinical research and advancing cancer treatment throughout
the region.
“This agreement is an important step for Auna in Mexico to continue
implementing the AunaWay,” said Suso Zamora, Executive Chairman and
President of Auna. “By bringing together some of the country’s
most respected oncology experts and consolidating our oncology services, we
are reinforcing our mission to provide the highest quality cancer care. With
this partnership, Auna is poised to become the leading oncology provider in
Monterrey.”
Dr. González de León and Dr. De la Peña Hinojosa added,
“We are thrilled as a team to join Auna’s mission to elevate
oncology care in Mexico. This collaboration allows us to enhance patient
care, drive research, and set new standards in oncology treatment by
partnering with the best in the industry.”
About Auna
Auna is a leading horizontally and vertically integrated healthcare platform
in Latin America with operations in Mexico, Peru, and Colombia, focusing on
high-complexity diseases. Our mission is to transform healthcare by providing
access to a highly integrated healthcare offering in the underpenetrated
markets of Spanish-speaking Americas. Founded in 1989, Auna has built one of
Latin America′s largest modern healthcare platforms that consists of a
horizontally integrated network of healthcare facilities and a vertically
integrated portfolio of oncological plans and selected general healthcare
plans. As of September 30, 2024, Auna’s network included 31 healthcare
network facilities, including hospitals, outpatient, prevention and wellness
facilities with 2,308 beds, and 1.3 million healthcare plans.
Forward-Looking Statements
This press release contains forward-looking statements. Forward-looking
statements convey our current expectations or forecasts of future events.
These statements involve known and unknown risks, uncertainties and other
factors which may cause our actual results, performance or achievements to
differ materially from the forward-looking statements that we make.
Forward-looking statements typically are identified by words or phrases such
as “may,” “will,” “expect,”
“anticipate,” “aim,” ”estimate,”
“intend,” “project,” “plan,”
“believe,” “potential,” “continue,”
“is/are likely to,” or other similar expressions. Forward-looking
statements that appear in a number of places in this press release include,
but are not limited to, statements regarding the intent, belief or current
expectations, regarding various matters, including, the expected impact of our
agreement with a physician group practicing at Opción Oncología
and our integration of their practice into Auna. Any or all of our
forward-looking statements in this press release may turn out to be
inaccurate. Our actual results could differ materially from those contained in
forward-looking statements due to a number of factors.
The forward-looking statements in this press release represent our
expectations and forecasts as of the date of this press release. Except as
required by law, we undertake no obligation to update or revise publicly any
forward-looking statements, whether as a result of new information, future
events or otherwise, after the date of this press release. For a discussion of
the risks facing the Company which could affect whether these forward-looking
statements are realized, see our Form F-1 filing with the U.S. Securities and
Exchange Commission.
For more information visit www.aunainvestors.com
Investor Relations Contact
contact@aunainvestors.com